Blood
Blood
Tissue
Tissue
Marrow
Marrow
Texas Cord Blood Bank
Texas Cord
Blood Bank

January 28, 2013

STBTC Board announces resignation of CEO Dennis Fallen

Linda Myers named Interim CEO

SAN ANTONIO- Dennis Fallen has resigned as CEO of South Texas Blood & Tissue Center (STBTC) and its affiliated organizations.  Linda Myers, president and chief operating officer of QualTex Laboratories, a sister affiliate of STBTC; will step in as interim CEO of the enterprise.  The announcements were made by STBTC Board Chair Dennis Stahl.

Fallen had become CEO in April, 2012.  Stahl said Fallen will be pursuing other business opportunities. 

Since 2011, Myers has been President and COO of QualTex, the nation’s largest independent, nonprofit testing laboratory for whole blood and plasma donations, headquartered in San Antonio with an additional location in Norcross, Georgia.  She joined QualTex in 2007 after spending 16 years at STBTC, where she had risen to the position of Vice President of Technical Services.  QualTex generated some $125 million in revenues in 2012, more than 65 percent of total enterprise revenues. 

In 2012, the Board created a holding company to oversee its two operating units, STBTC and QualTex.  While the holding company has not yet been named, the Board’s intent is that the holding company will serve as a means to grow the enterprise, reflecting its capabilities in blood, tissue, bone marrow, cord blood, regenerative medicine, research and biologic testing, Stahl said. 

“We wish Dennis Fallen well as he moves on and appreciate his contributions to the organization,” Stahl said.  “Linda Myers is a very strong executive who understands all aspects of the enterprise and has achieved great success in growing the national presence of QualTex Laboratories.  She will provide a steady hand as we begin the search for a new chief executive officer.”

“This organization is exceptionally strong, not only in its traditional role as a leading provider of blood and tissue to hospitals and their patients, but also as a growing force in San Antonio’s bioscience industry,” he said.

Media Resource Image


Linda Myers named Interim CEO